Hypertension and Lorundrostat: Key Discoveries From the TARGET-HTN Trial
Hypertension and Lorundrostat: Key Discoveries From the TARGET-HTN Trial is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Hypertension and Lorundrostat: Key Discoveries From the TARGET-HTN Trial have?
Hypertension and Lorundrostat: Key Discoveries From the TARGET-HTN Trial has 11 citations in the OpenAlex counts ScholarIQ stores.
When was Hypertension and Lorundrostat: Key Discoveries From the TARGET-HTN Trial published?
Hypertension and Lorundrostat: Key Discoveries From the TARGET-HTN Trial has 2023 year in the ScholarIQ index.
What is the open-access status of Hypertension and Lorundrostat: Key Discoveries From the TARGET-HTN Trial?
Hypertension and Lorundrostat: Key Discoveries From the TARGET-HTN Trial has closed oa status in the ScholarIQ index.
What is the DOI of Hypertension and Lorundrostat: Key Discoveries From the TARGET-HTN Trial?
The DOI for Hypertension and Lorundrostat: Key Discoveries From the TARGET-HTN Trial is on the source record.
What is the PMID of Hypertension and Lorundrostat: Key Discoveries From the TARGET-HTN Trial?
The PMID for Hypertension and Lorundrostat: Key Discoveries From the TARGET-HTN Trial is on the source record.
What is the OpenAlex record for Hypertension and Lorundrostat: Key Discoveries From the TARGET-HTN Trial?
The OpenAlex for Hypertension and Lorundrostat: Key Discoveries From the TARGET-HTN Trial is on the source record.